{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:50:38Z","timestamp":1793829038233,"version":"4.6.1"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"47","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11,21]]},"abstract":"<jats:p>\n                    Gastric cancer (GC) remains one of the leading causes of cancer mortality worldwide. The tumor immune microenvironment plays a pivotal role in GC progression, with regulatory T cells (Tregs), particularly the CD4+ CD39+ subset, implicated in immune suppression. However, the causal role of CD4+ CD39+ Treg cells in GC remains unclear. Additionally, CD5, a T cell surface glycoprotein, may influence immune responses in cancer. This study aims to clarify the relationship between CD4+ CD39+ Treg cells and GC risk and explore the potential mediating role of CD5 using a Mendelian randomization (MR) approach. A bidirectional 2-sample MR analysis was conducted using genome-wide association study data. CD4+ CD39+ Treg cell data were sourced from the IEU genome-wide association study database (N\u2005=\u20052920), and GC data were retrieved from the FennGenn consortium (N\u2005=\u20052,88,444; 1307 cases, 2,87,137 controls). Analyses included inverse variance weighted, MR-Egger regression, weighted median, and Mendelian randomization-Pleiotropy RESidual Sum and Outlier to test robustness and pleiotropy. A 2-step MR was performed to evaluate the mediating role of CD5. Results indicated that increased CD4+ CD39+ Treg cell levels were associated with a reduced risk of GC (odds ratio [OR]\u2005=\u20050.907, 95% confidence interval [CI]\u2005=\u20050.829\u20130.993,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.035). No heterogeneity or pleiotropy was observed, and reverse causality was excluded (OR\u2005=\u20050.983, 95% CI\u2005=\u20050.931\u20131.038,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.530). Additionally, CD4+ CD39+ Treg cells influenced CD5 expression (OR\u2005=\u20050.970, 95% CI\u2005=\u20050.943\u20130.998,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.035), and elevated CD5 levels were linked to increased GC risk (OR\u2005=\u20051.285, 95% CI\u2005=\u20051.030\u20131.603,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.026). Mediation analysis revealed that CD5 accounted for 7.74% of the protective effect of CD4+ CD39+ Treg cells on GC. CD4+ CD39+ Treg cells are causally linked to a reduced risk of GC, with CD5 mediating a small but significant portion of this protective effect. These findings highlight the importance of immune regulation in GC and suggest that targeting CD5 could be a therapeutic strategy. Further research is needed to investigate additional mediators contributing to GC development.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000045665","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:03:07Z","timestamp":1764169387000},"page":"e45665","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["CD5 mediates the link between CD4+ CD39+ activated Treg cells and gastric cancer: A Mendelian randomization study"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-1291-8349","authenticated-orcid":false,"given":"Qiao","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Gastrointestinal Weight Loss Metabolism and Hernia Surgery, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang City, Henan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuezhi","family":"Zhou","sequence":"additional","affiliation":[{"name":"College of Medical Engineering, Xinxiang Medical University, Xinxiang City, Henan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang City, Henan Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjun","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Weight Loss Metabolism and Hernia Surgery, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang City, Henan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dezhong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Weight Loss Metabolism and Hernia Surgery, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang City, Henan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohui","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Weight Loss Metabolism and Hernia Surgery, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang City, Henan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260514","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 Cancers in 185 Countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R2-20260514","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41571-023-00747-0","article-title":"Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention.","volume":"20","author":"Aaron","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"R3-20260514","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.annonc.2022.07.004","article-title":"Gastric cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up.","volume":"33","author":"Lordick","year":"2022","journal-title":"Ann Oncol"},{"key":"R4-20260514","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/cac2.12197","article-title":"Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on global epidemiological data released in 2020.","volume":"41","author":"Qi","year":"2021","journal-title":"Cancer Commun (Lond)"},{"key":"R5-20260514","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ccell.2023.01.009","article-title":"Metabolic programming and immune suppression in the tumor microenvironment.","volume":"41","author":"Andrejeva","year":"2023","journal-title":"Cancer Cell"},{"key":"R6-20260514","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: the cancer-immunity cycle.","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"key":"R7-20260514","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.4110\/in.2023.23.e2","article-title":"Shaping heterogeneity of naive CD8+ T cell pools.","volume":"23","author":"Lee","year":"2023","journal-title":"Immune Netw"},{"key":"R8-20260514","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1600-0463.2004.apm1121001.x","article-title":"CD4+CD25+ regulatory T cells: phenotype and physiology.","volume":"112","author":"Hori","year":"2004","journal-title":"APMIS"},{"key":"R9-20260514","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41590-023-01588-w","article-title":"Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets.","volume":"24","author":"Zhao","year":"2023","journal-title":"Nat Immunol"},{"key":"R10-20260514","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12943-023-01714-0","article-title":"Regulatory cells and the effect of cancer immunotherapy.","volume":"22","author":"Iglesias-Escudero","year":"2023","journal-title":"Mol Cancer"},{"key":"R11-20260514","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41588-020-0684-4","article-title":"Complex genetic signatures in immune cells underlie autoimmunity and inform therapy.","volume":"52","author":"Orru","year":"2020","journal-title":"Nat Genet"},{"key":"R12-20260514","doi-asserted-by":"crossref","first-page":"104755","DOI":"10.1016\/j.cellimm.2023.104755","article-title":"HIF-1\u03b1 regulates the expression of the non-conventional isoform of the CD5 gene in T cells under hypoxic conditions: a potential mechanism for CD5neg\/low phenotype of infiltrating cells in solid tumors.","volume":"391-392","author":"Khera","year":"2023","journal-title":"Cell Immunol"},{"key":"R13-20260514","doi-asserted-by":"crossref","first-page":"14342","DOI":"10.1073\/pnas.1922525117","article-title":"CD5 dynamically calibrates basal NF-\u03baB signaling in T cells during thymic development and peripheral activation.","volume":"117","author":"Mueller","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"R14-20260514","doi-asserted-by":"crossref","DOI":"10.1126\/science.abg2752","article-title":"CD5 expression by dendritic cells directs T cell immunity and sustains immunotherapy responses.","volume":"379","author":"He","year":"2023","journal-title":"Science"},{"key":"R15-20260514","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1001\/jama.2017.17219","article-title":"Mendelian randomization.","volume":"318","author":"Emdin","year":"2017","journal-title":"JAMA"},{"key":"R16-20260514","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/jrsm.1346","article-title":"Meta-analysis and Mendelian randomization: a review.","volume":"10","author":"Burgess","year":"2019","journal-title":"Res Synth Methods"},{"key":"R17-20260514","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population.","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"R18-20260514","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature09534","article-title":"A map of human genome variation from population-scale sequencing.","volume":"467","author":"Abecasis","year":"2010","journal-title":"Nature"},{"key":"R19-20260514","doi-asserted-by":"crossref","first-page":"e34408","DOI":"10.7554\/eLife.34408","article-title":"The MR-Base platform supports systematic causal inference across the human phenome.","volume":"7","author":"Hemani","year":"2018","journal-title":"Elife"},{"key":"R20-20260514","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1093\/bioinformatics\/btz469","article-title":"PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations.","volume":"35","author":"Kamat","year":"2019","journal-title":"Bioinformatics"},{"key":"R21-20260514","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10654-019-00578-3","article-title":"Genetic instrumental variable analysis: time to call Mendelian randomization what it is: the example of alcohol and cardiovascular disease.","volume":"35","author":"Mukamal","year":"2020","journal-title":"Eur J Epidemiol"},{"key":"R22-20260514","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in Mendelian randomization studies.","volume":"40","author":"Burgess","year":"2011","journal-title":"Int J Epidemiol"},{"key":"R23-20260514","doi-asserted-by":"crossref","first-page":"252","DOI":"10.12688\/wellcomeopenres.16374.2","article-title":"MendelianRandomization v0.5.0: updates to an R package for performing Mendelian randomization analyses using summarized data.","volume":"5","author":"Brion","year":"2020","journal-title":"Wellcome Open Res"},{"key":"R24-20260514","doi-asserted-by":"crossref","first-page":"a040980","DOI":"10.1101\/cshperspect.a040980","article-title":"Using Mendelian randomization to improve the design of randomized trials.","volume":"11","author":"Fernandez","year":"2021","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R25-20260514","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1093\/ije\/dyx102","article-title":"Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption.","volume":"46","author":"Hartwig","year":"2017","journal-title":"Int J Epidemiol"},{"key":"R26-20260514","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R27-20260514","doi-asserted-by":"crossref","first-page":"113","DOI":"10.12688\/wellcomeopenres.15334.1","article-title":"Using the MR-Base platform to investigate risk factors and drug targets for thousands of phenotypes.","volume":"4","author":"Walker","year":"2019","journal-title":"Wellcome Open Res"},{"key":"R28-20260514","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/s41467-020-14452-4","article-title":"Exploiting horizontal pleiotropy to search for causal pathways within a Mendelian randomization framework.","volume":"11","author":"Cho","year":"2020","journal-title":"Nat Commun"},{"key":"R29-20260514","doi-asserted-by":"crossref","first-page":"6490","DOI":"10.1038\/s41467-022-34164-1","article-title":"Mendelian randomization accounting for complex correlated horizontal pleiotropy while elucidating shared genetic etiology.","volume":"13","author":"Cheng","year":"2022","journal-title":"Nat Commun"},{"key":"R30-20260514","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1186\/s12967-022-03691-2","article-title":"Causality of genetically determined metabolites on anxiety disorders: a two-sample Mendelian randomization study.","volume":"20","author":"Xie","year":"2022","journal-title":"J Transl Med"},{"key":"R31-20260514","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10654-021-00757-1","article-title":"Mendelian randomisation for mediation analysis: current methods and challenges for implementation.","volume":"36","author":"Relton","year":"2021","journal-title":"Eur J Epidemiol"},{"key":"R32-20260514","doi-asserted-by":"crossref","first-page":"1054206","DOI":"10.3389\/fendo.2022.1054206","article-title":"Genetically predicted C-reactive protein mediates the association between rheumatoid arthritis and atlantoaxial subluxation.","volume":"13","author":"Yu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R33-20260514","doi-asserted-by":"crossref","first-page":"844142","DOI":"10.3389\/fimmu.2022.844142","article-title":"Immunotherapy: reshape the tumor immune microenvironment.","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"R34-20260514","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/bjc.2017.220","article-title":"HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer.","volume":"117","author":"Byrne","year":"2017","journal-title":"Br J Cancer"},{"key":"R35-20260514","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/cr.2016.151","article-title":"Regulatory T cells in cancer immunotherapy.","volume":"27","author":"Tanaka","year":"2017","journal-title":"Cell Res"},{"key":"R36-20260514","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.2741\/2841","article-title":"The role of T-regulatory cells in pregnancy and cancer.","volume":"13","author":"Wilczynski","year":"2008","journal-title":"Front Biosci"},{"key":"R37-20260514","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1111\/febs.13656","article-title":"Targeting regulatory T cells in tumors.","volume":"283","author":"Liu","year":"2016","journal-title":"FEBS J"},{"key":"R38-20260514","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/ni.2420","article-title":"A multiply redundant genetic switch \u201clocks in\u201d the transcriptional signature of regulatory T cells.","volume":"13","author":"Fu","year":"2012","journal-title":"Nat Immunol"},{"key":"R39-20260514","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.immuni.2019.01.020","article-title":"Human FOXP3+ regulatory T cell heterogeneity and function in autoimmunity and cancer.","volume":"50","author":"Wing","year":"2019","journal-title":"Immunity"},{"key":"R40-20260514","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev-immunol-042718-041717","article-title":"Regulatory T cells and human disease.","volume":"38","author":"Sakaguchi","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"R41-20260514","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3389\/fimmu.2018.01048","article-title":"Foxp3+ T regulatory cells: still many unanswered questions \u2013 a perspective after 20 years of study.","volume":"9","author":"Shevach","year":"2018","journal-title":"Front Immunol"},{"key":"R42-20260514","doi-asserted-by":"crossref","first-page":"8068","DOI":"10.3390\/ijms22158068","article-title":"CD39 regulation and functions in T cells.","volume":"22","author":"Timperi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R43-20260514","doi-asserted-by":"crossref","first-page":"114180","DOI":"10.1016\/j.biopha.2022.114180","article-title":"Targeting regulatory T cells in gastric cancer: pathogenesis, immunotherapy, and prognosis.","volume":"158","author":"Wang","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"R44-20260514","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1002\/eji.201142347","article-title":"Phenotypic and functional characteristics of CD4+CD39+FOXP3+ and CD4+CD39+FOXP3neg T-cell subsets in cancer patients.","volume":"42","author":"Simoni","year":"2012","journal-title":"Eur J Immunol"},{"key":"R45-20260514","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/JLB.MR0618-226R","article-title":"The multiple faces of CD5.","volume":"105","author":"Burgue\u00f1o-Bucio","year":"2019","journal-title":"J Leukoc Biol"},{"key":"R46-20260514","doi-asserted-by":"crossref","first-page":"12969","DOI":"10.1073\/pnas.1917182117","article-title":"CD5 signalosome coordinates antagonist TCR signals to control the generation of Treg cells induced by foreign antigens.","volume":"117","author":"Garcia","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"R47-20260514","first-page":"2522","article-title":"CCL11 increases the proportion of CD4+CD25+Foxp3+ Treg cells and the production of IL-2 and TGF-\u03b2 by CD4+ T cells via the STAT5 signaling pathway.","volume":"21","author":"Wang","year":"2020","journal-title":"Mol Med Rep"},{"key":"R48-20260514","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1158\/2326-6066.CIR-20-0270","article-title":"CD39 identifies the CD4+ tumor-specific T-cell population in human cancer.","volume":"8","author":"Kortekaas","year":"2020","journal-title":"Cancer Immunol Res"},{"key":"R49-20260514","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.2174\/0115680266275768231027100120","article-title":"Natural plant products mediated prevention of cancer facilitated through immune suppression of treg cells.","volume":"23","author":"Oishi","year":"2023","journal-title":"Curr Top Med Chem"},{"key":"R50-20260514","first-page":"197","article-title":"Expression of CD4+CD25+ regulatory T cells and Foxp3 in peripheral blood of patients with gastric carcinoma.","volume":"30","author":"Chen","year":"2016","journal-title":"J Biol Regul Homeost Agents"},{"key":"R51-20260514","doi-asserted-by":"crossref","first-page":"e13129","DOI":"10.1111\/sji.13129","article-title":"Targeting regulatory T cells in anti-PD-1\/PD-L1 cancer immunotherapy.","volume":"95","author":"Zhang","year":"2022","journal-title":"Scand J Immunol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045665","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:07:03Z","timestamp":1778756823000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":51,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045665","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"2025-03-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}